Skip to content
Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    Most Viewed

    The Old Farmer’s Almanac Has Spoken on Mississippi’s Fall Forecast

    July 25, 2025

    Old Sayings Say It Best

    May 22, 2024

    Actor Jeremy London Calls Mississippi Home

    August 1, 2024

    Snoop Dogg’s Mississippi Roots Run Deep

    October 22, 2024
    Facebook X (Twitter) Instagram
    Monday, November 16, 2026
    Trending
    • Monday Night Dinner: Grandma’s Chicken and Dressing Casserole
    • Picayune Prepares The Oaks for Annual Christmas Celebration
    • Pike County Little Theatre Presents “Another Sleigh Ride Through Time” This December
    • A Make–Do Water Sampler Does the Job
    • Mississippi High School Football Playoffs Heat Up as All Seven Classifications Take the Field
    Facebook X (Twitter) Instagram YouTube TikTok
    Login
    Our Mississippi HomeOur Mississippi Home
    • Living

      The Recipes We Don’t Write Down

      November 10, 2026

      Two States, One Salute: How Mississippi and Massachusetts Honor Veterans Day

      November 10, 2026

      A Tale of Two Falls

      November 9, 2026

      A Lifelong Teaching Lesson

      November 6, 2026

      An Attitude of Gratitude: Finding More to Be Thankful for This November

      November 2, 2026
    • Arts / Culture

      Pike County Little Theatre Presents “Another Sleigh Ride Through Time” This December

      November 16, 2026

      Southern Miss Powwow Returns for 23rd Year

      November 13, 2026

      OOMA Brings Art and Community Together with Free After Hours Event Featuring Artist Christopher Saucedo

      November 11, 2026

      All Roads (and Rails) Lead to Ocean Springs for the Peter Anderson Festival

      November 2, 2026

      Keb’ Mo’ brings soulful blues to MSU-Meridian Nov. 13

      October 29, 2026
    • Entertainment

      All Roads (and Rails) Lead to Ocean Springs for the Peter Anderson Festival

      November 2, 2026

      Keb’ Mo’ brings soulful blues to MSU-Meridian Nov. 13

      October 29, 2026

      University Forum Brings Grateful Dead Celebration Downtown

      October 28, 2026

      Southern Miss Symphony Conjures a Halloween Escape with ‘Fright Night!’

      October 26, 2026

      The Jackson County Blue Ribbon Fair Returns with Food, Rides, and Fun

      October 19, 2026
    • Food & Dining

      Monday Night Dinner: Grandma’s Chicken and Dressing Casserole

      November 16, 2026

      Sunday Supper, All on One Pan: A Meal Worth Gathering Around

      November 8, 2026

      A Pot of Comfort: Creamy Chicken and Wild Rice Soup

      November 1, 2026

      A Little Hocus Pocus in the Kitchen: Halloween Monster Cookies

      October 28, 2026

      A Fall Sunday Favorite: Creamy Sausage and Potato Soup

      October 18, 2026
    • Environment

      A Make–Do Water Sampler Does the Job

      November 14, 2026

      Winter Birding – Lots to See and Hear

      November 7, 2026

      MSU to Lead New Feed the Future Innovation Lab for Fish

      October 23, 2026

      The Secret Lives of Pollinators 

      October 17, 2026

      Fifty Years of Conservation on the Pascagoula River

      October 16, 2026
    • Lagniappe
      • Business
      • Sports
      • Education
      • Health & Wellness
      • OurMSVoices
      • People
    Subscribe
    Our Mississippi HomeOur Mississippi Home
    Home»Education»Researchers Break Cancer’s ‘Shield’ in New Metastasis Study
    Education Health & Wellness

    Researchers Break Cancer’s ‘Shield’ in New Metastasis Study

    University of MississippiBy University of MississippiDecember 15, 20254 Mins Read60 Views
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Postdoctoral researcher Veeresh Toragall (left) and Thomas Werfel, associate professor of biomedical engineering at the University of Mississippi, work in the Interdisciplinary NanoBioSciences Lab in Barnard Hall. Toragall and Werfel recently published research that shows that a existing drug, ifetroban, may be used to slow the spread of cancer. Photo by Srijita Chattopadhyay/Ole Miss Digital Imaging Services
    Share
    Facebook Twitter LinkedIn Pinterest Email Copy Link

    OXFORD, Miss. – Aggressive cancers can use blood vessels like roadways, speeding through the body and finding new places to grow. But new research shows that a drug in clinical trials may help stop the spread of cancer before it reaches its destination.

    University of Mississippi research shows that ifetroban, an anti-platelet drug, can help the immune system better identify and remove cancer cells that have entered the bloodstream. Stopping metastasis, the process by which cancers spread, would take the teeth out of aggressive diseases such as breast, lung and pancreatic cancers.

    “The spread of cancer is what kills people,” said Thomas Werfel, associate professor of biomedical engineering. “We can treat local cancer – it’s the metastatic cancer that’s really devastating, and that’s what we’re targeting.”

    A hand wearing a blue latex glove holds a vial of liquid in a laboratory.
    Ifetroban, a anti-platelet drug already proven safe for human use, may effectively slow the spread of aggressive cancer, according to a new study published in Experimental Hematology and Oncology. Photo by Srijita Chattopadhyay/Ole Miss Digital Imaging Services

    When cancer cells enter the bloodstream, they form bonds with blood platelets, effectively creating a “shield” around the cancer cell that hides it from white blood cells and other agents of the immune system. Ifetroban stops those platelet bonds from forming, which allows the immune system to target and remove cancer cells before they spread to a new location.

    “Once cancer enters the metastatic stage, survivability goes way down,” said Veeresh Toragall, postdoctoral researcher in the Department of Biomedical Engineering. “What we are thinking is that we target the metastasis, the spread of cancer. In this case, what we have done is a very simple thing: we have reduced the interaction between the platelets and the tumor cells.

    “Once you take out the interaction between these two, the platelets are no longer safeguarding the circulating tumor cells in the body. So, the body’s immune system is free to attack these tumor cells and remove them.”

    The study, published in Experimental Hematology and Oncology, tested ifetroban’s ability to stop platelet shielding in triple-negative breast cancer, a particularly aggressive disease that accounts for 1 in 10 breast cancer diagnoses.Previous studies have shown that triple-negative breast cancer is associated with higher activity of TPr, a receptor that helps platelets stick to tumor cells.

    “So, the question was, how effective would it be to target TPr and block it?” Werfel said. “We know that TNBC is a very metastatic disease, and it made sense for us to try to reduce metastasis as a way to reduce mortality.”

    The study showed ifetroban reduced lung metastases by 67%, liver metastases by 60% in animal models and reduced overall circulating tumor cells by more than 50%.

    A young man wearing a white coat works in a laboratory.
    Postdoctoral researcher Veeresh Toragall works in the Interdisciplinary NanoBioSciences Lab in Barnard Hall. Toragall and Thomas Werfel, associate professor of biomedical engineering, recently published research on how an extant anti-platelet drug may help slow the spread of aggressive cancers. Photo by Srijita Chattopadhyay/Ole Miss Digital Imaging Services

    “Right now, there are very few – if any – drugs that are approved to specifically target metastasis,” Werfel said. “This is not going to replace other cancer drugs. You’re still going to want cytotoxic therapy to kill the cancer cells.

    “But while you’re killing them, you know they’re not going to other places and creating new tumors.”

    Because ifetroban has already been tested for safety in more than 1,400 patients in previous clinical trials, it could become a cancer therapy much more quickly than traditional drug-discovery timelines.

    “This drug has already been studied for other uses and it’s in clinical trials right now,” Toragall said. “This shortens the timeline to approval for the treatment of cancer metastasis.

    “We won’t have to wait 15 years to get this on the market if it’s found to be safe and effective in cancer clinical trials.”

    This material is based on work supported by the American Cancer Society grant nos. RSG-21-114-01-MM to TW and by the National Institutes of Health grant no. P20 GM104357. The research was conducted in collaboration with the University of Mississippi Medical Center and supported by Cumberland Pharmaceuticals, which provided the investigational drug ifetroban.

     

    Previous ArticleHegwood Novel on Short List for Book of the Year
    Next Article A Year in Review: Celebrating the Best of Southern Miss in 2025
    University of Mississippi

    Founded in 1848, the University of Mississippi, affectionately known to alumni, students and friends as Ole Miss, is Mississippi's flagship university. Included in the elite group of R-1: Doctoral Universities - Highest Research Activity by the Carnegie Classification, it has a long history of producing leaders in public service, academics and business. With more than 24,000 students, Ole Miss is the state's largest university and is ranked among the nation's fastest-growing institutions.

    Related Posts

    Arts / Culture

    Southern Miss Powwow Returns for 23rd Year

    November 13, 2026
    Education

    Retired Veteran Hikes Appalachian Trail to Support Ole Miss Veterans

    November 12, 2026
    Education

    Growing More Than Food: Galloway Family Farm Cultivates Knowledge and Community

    November 9, 2026
    Add A Comment

    Comments are closed.

    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • Twitter
    • Instagram

    Subscribe to Updates

    Get the latest good news happening in Mississippi!

    Most Popular

    The Old Farmer’s Almanac Has Spoken on Mississippi’s Fall Forecast

    July 25, 20258K Views

    Old Sayings Say It Best

    May 22, 20248K Views

    Actor Jeremy London Calls Mississippi Home

    August 1, 20247K Views
    Our Picks

    Monday Night Dinner: Grandma’s Chicken and Dressing Casserole

    November 16, 2026

    Picayune Prepares The Oaks for Annual Christmas Celebration

    November 16, 2026

    Pike County Little Theatre Presents “Another Sleigh Ride Through Time” This December

    November 16, 2026

    Subscribe to Updates

    Get the latest good news from Our Mississippi Home.

    Our Mississippi Home
    Facebook X (Twitter) Instagram YouTube TikTok RSS
    • About OurMSHome
    • Advertise
    • Community Partners
    • Privacy Policy
    • Guidelines
    • Terms
    © 2026 Our Mississippi Home. Designed by Know_Name.

    Type above and press Enter to search. Press Esc to cancel.

    Ad Blocker Enabled!
    Ad Blocker Enabled!
    Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?